EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000007100
Gene Symbol: TAAR1
1 Cross references
421 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000000681
Gene Symbol: TAAR1
1 Cross references
421 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000019267
Gene Symbol: TAAR1
1 Cross references
425 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000015088
Gene Symbol: TAAR1
1 Cross references
389 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000019154
Gene Symbol: TAAR1
2 Cross references
369 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000019332
Gene Symbol: TAAR1
3 Cross references
425 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCVAG00000015129
Gene Symbol: TAAR1
1 Cross references
387 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCVAG00000001310
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Trichohyalin-Like

Ensembl ID : ENSCVAG00000003313
Gene Symbol: LOC107087152
2 Cross references
194 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSCVAG00000006915
Gene Symbol: LOC107101475
3 Cross references
177 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCVAG00000005576
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCVAG00000000406
Gene Symbol: TUBA4A
4 Cross references
108 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).